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Objective. To evaluate the diagnostic benefit of real-time elastography (RTE) in clinical routine. Strain indices (SI) for benign and
malignant tumors were assessed. Methods. 100 patients with 110 focal breast lesions were retrieved. Patients had mammography
(MG), ultrasound (US), and, if necessary, MRI. RTE was conducted after ultrasound. Lesions were assessed with BI-RADS for
mammography and ultrasound. Diagnosis was established with histology or follow-up. Results. SI for BI-RADS 2 was 1.71 ± 0.86.
Higher SI (2.21±1.96)was observed for BI-RADS 3 lesions. SI of BI-RADS4 and 5 lesionswere significantly higher (16.92±20.89 and
19.54±10.41). 31 malignant tumors exhibited an average SI of 16.13±14.67; SI of benign lesions was 5.29±11.87 (𝑃 value < 0.0001).
ROC analysis threshold was >3.8 for malignant disease. Sensitivity of sonography was 90.3% (specificity 78.5%). RTE showed a
sensitivity of 87.1% (specificity 79.7%). Accuracy of all modalities combined was 96.8%. In BI-RADS 3 lesions RTE was able to
detect all malignant lesions (sensitivity 100%, specificity 92.9%, and accuracy 93.9%). Conclusions. RTE increased sensitivity and
specificity for breast cancer detection when used in combination with ultrasound.
1. Introduction
Breast cancer is one of the most common cancers occurring
in women [1], but sensitive diagnostic imaging modalities
that detect cancer early are frequently limited by their low
specificity. In addition to digital mammography, ultrasound
has been established as a valuable tool for making early
diagnoses, especially for focal masses in dense breast glands
[2]. The first clinical uses of real-time strain elastography for
mammary lesions were described between 1997 and 2003 [3–
5]. Real-time elastography (RTE) can be rapidly and easily
performed along with a B-scan and Doppler ultrasound dur-
ing the same session.This procedure can aid in identifying the
lesion’s morphological features and in obtaining information
regarding the tissue’smechanical characteristics [6]. Itoh et al.
[7] established a scoring system to morphologically classify
lesions in a manner analogous to the Breast Imaging and
Reporting Data System (BI-RADS) [8].
RTE can be used to monitor mechanical tissue properties
via an ultrasound probe that calculates the strain produced by
an externally applied force. Using the combined autocorrela-
tionmethod (CAM), data regarding tissue displacement prior
to and following the compression is measured and merged
with the conventional B-mode image [7, 9]. In addition
to the morphological information, the result of these two
measurements is the so-called “strain index,” representing a
semiquantitative evaluation obtained by comparing the strain
levels of different normal-appearing areas of the breast with
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Figure 1: Principal study design: imaging work-up of lesions and classification by mammography, ultrasound, and real-time elastography.
MRI was conducted if necessary.
the strain level of the lesion on the elasticity maps. A higher
strain index (SI) indicates less strain in the measured lesions.
This score also correlates with the stiffness of a palpable mass
in physical breast examinations. Importantly, mostmalignant
tumors are less compressible than the surrounding tissue,
similar to what can be observed with manual palpations.
Although a conventional ultrasound can differentiate
focal lesions from normal tissue to some extent, histopathol-
ogy is the standard of reference. A conventional sonography
in combination with RTE should therefore increase the
sensitivity for breast cancer diagnoses [10]. One aim was
therefore to further consolidate results obtained in those
previous studies.
We examined the impact of RTE to a morphologic
ultrasound examination along with a mammogram on sensi-
tivity and specificity for malignant disease. Furthermore, the
influence of the diameter of the lesion on the strain index was
examined. Finally, we correlated histopathologic tumor entity
and the strain indices.
2. Materials and Methods
This studywas approved by the ethics committee andwas per-
formed according to the standards of good clinical practice
(GCP). Standards for the reporting of diagnostic accuracy
studies (STARD criteria) were applied. Because additional
RTE was performed along with the routine ultrasound,
written informed consent from the patients waswaived. From
the women undergoing routine mammography screening
between February 2008 and February 2009 a total of 105 con-
secutive patients were retrospectively recruited.The principle
study design is displayed in Figure 1. Inclusion criteria were
a BI-RADS classification based on mammography of 0, 2, 3,
4, and 5, with an additional workup with ultrasonography.
All of the patients were female and had a median age of 53
years (range: 26 to 87 years). All of the imaging examinations
were classified in consensus by two radiologists with 10
and 2 years of experience in breast imaging according to
the BI-RADS classification referring to mammography and
sonography (Table 1). BI-RADS classification was conducted
in every single case for mammography. Patients with known,
focal malignancies (BI-RADS 6) and patients with normal
negativemammography (BI-RADS 1) were not included. Five
patients were excluded due to missing compliance for follow-
up examination. All other BI-RADS scores were further
investigated by sonography and Doppler ultrasound and
were then reclassified (Figure 1). 26 patients with lesions
still needing additional imaging evaluation (BI-RADS 0 and
uncertain BI-RADS 3 or 4) underwent further breast MR-
imaging and were reclassified again (Figure 1). All patients
with a final BI-RADS score of 4 or 5 received a diagnostic 16G
core biopsy or open surgery was performed to determine the
histopathologic diagnosis, as recommended by the American
College of Radiology [8]. For BI-RADS 3 lesions a 6-month
follow-up mammography and ultrasound was performed.
If there was no change in the follow-up exam, another
mammography and ultrasoundwere conducted after another
6 months. A stable lesion was reexamined after one year to
prove the benign nature. Changes in lesion characteristics
resulted in upgrading of the BI-RADS assessment and appro-
priate further actions were taken (histology). The remaining
BI-RADS 2 lesions were examined in a regular follow-up
period of 2 years.
3. Mammography
Each patient was questioned regarding their familial risk
factors, and a clinical exam (inspection, palpation) preceded
the imaging procedures. The findings were documented on
a standardized evaluation form. In patients under 40 years
of age, mammography was indicated if there were familial
risks or clinical findings. Mammography was available for all
of the patients in two standard projections, craniocaudal and
oblique.The same physicians who performed the sonography
and real-time elastosonography also immediately viewed all
mammography results with the patient in the waiting room.
The density of the breast was classified according to the
American College of Radiology (ACR) type, and the lesions
were classified according to the BI-RADS system.
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Table 1: ACR BIRADS categories in ultrasound: ultrasound assessment categories as proposed by the ACR (BI-RADS).
0 Need for additional imaging evaluation.
The final assessment category cannot be determined by ultrasound. Further imaging studies involve mammography and MRI.
1 Negative.
In this category, no lesions are found on ultrasound. There are no mass forming processes or calcifications present.
2 Benign findings.
Lesions in this category do not require further imaging.
3 Probably benign finding—short-interval follow-up is recommended.
In the ACR recommendations, this category consists of lesions with circumscribed margins, oval shape, and horizontal orientation.
Further, complicated cysts may also be placed in this group.
4 Suspicious abnormality—biopsy should be considered.
The ACR states that lesions belonging to this category exhibit a probability of cancer ranging from 3% to 94%. Those lesions are always
biopsied at our institution.
5 Highly suggestive of malignancy—appropriate action should be taken.
The risk of cancer is above 95%. Those lesions require core biopsy and/or excision. Staging for lymph node involvement is mandatory.
6 Biopsy-proven malignancy—appropriate action should be taken.
Copyright Notice
American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Reston, VA: ©American College of Radiology. 2003.
All rights reserved.
(1) The italicized text is explanatory but not part of the BI-RADS assessments and should not be represented as such.
4. Ultrasound
An ultrasound was performed following the mammography
on the same day. An ultrasound exam was indicated for the
following patient or case characteristics: dense breasts of ACR
Type III and IV, palpable lesions (BI-RADS 0), or a suspicious
lesion detected on mammography (BI-RADS 2–5).
A diagnostic ultrasound systemmade by Hitachi Medical
Corporation was used for all examinations (Hitachi model
Hi-Vision 900; Hitachi Medical Corporation, Tokyo, Japan).
Linear probes were used for both ultrasound breast imaging
and elastography.These probes provide a steady compression
and a homogenous strain in the area of interest. The present
study was performed using the Hitachi probe model EUP L-
74M (13MHz). The patients were positioned on a standard
patient stretcher and slightly elevated at 20 degrees. To
improve the sonographic conditions, the patients were asked
to position their hands behind their neck. Following the
application of a conventional ultrasound gel, the different
sectors of the breast were examined for focal lesions using
the linear probe. The breast glands were searched system-
atically for focal lesions using a radial scanning pattern.
Each breast was divided into 5 sections: 4 outer quadrants
of the same size and the retroareolar region. According to
the ACR-BI-RADS ultrasound classification criteria lesions
were consideredmalignant if one of the following criteria was
evident: irregular shape, spiculated margins, irregular lesion
boundary, and echo pattern (i.e., complex echo patterns
like both echoic and anechoic components, complicated,
cystic patterns). Posterior acoustic behavior, architectural
distortion of the surrounding tissue, calcification, and vas-
cularity were also taken into consideration. In addition, the
focal lesions were classified into groups according to their
diameter, which was determined using B-mode sonography.
The classifications were stratified into ten-millimeter groups
as follows: 1–10mm, 11 to 20mm, and >21mm.
Elastography was performed after the ultrasound study
was conducted. Three strain indices of the suspected lesion
were documented in the patient reports. The elastography
software by Hitachi indicated the pressure amplitude on the
screen to avoid placing too much pressure on the tissue and
to get reproducible values. For the elasticity measurements,
a region of interest (ROI) was positioned over both, (1) the
focal lesion and (2) homogenous breast tissue. The first ROI
over the suspected lesion was drawn as large as possible to
cover the whole lesion. The latter ROI (at least 2 cm) served
as a reference for the software to calculate the tissue strain in
the lesion (Figures 2 and 3).
5. Magnetic Resonance Imaging
In 26 cases, additional magnetic resonance imaging (MRI)
was performed using a 1.5 tesla MRI unit (Siemens Sonata,
Erlangen, Germany). The standardized protocol consisted of
axial T2-weighted and turbo-inversion-recovery sequences
and a 3D T1-weighted gradient echo sequence (fast low-angle
shot). The contrast dynamics were determined using an
intravenous paramagnetic contrast agent in standard dosage
(Gadolinium; Dotarem 0.5mmol/mL; Guerbet, Roissy,
France). Six measurements including precontrast imaging
lasting about 1 minute each were acquired continuously.
Diffusion-weighted imaging and transverse fat-suppressed
T1-weighted turbo-spin echo sequences were used to
complete the protocol. The matrix size was 320 × 320
for the dynamic imaging and 512 × 512 voxels for the
T2-weighted and turbo inversion recovery sequences.
Criteria for malignancy were irregular margins, invasion
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Figure 2: The right side of the figure shows an ultrasonographic
image (B-mode) of a 56-year-old female patient suffering from an
invasive ductal carcinoma. The first region of interest (ROI A) is
positioned in the center of the hypoechoic tumor and was compared
with the reference ROI B, which contains the normal glandular
tissue. On the left side of the image, the stiffness of the different
tissues is color-coded and superimposed on the grayscale image.The
carcinoma is less compressible than the surrounding normal tissue.
The strain index in this case was 14.3, suggesting malignancy.
Figure 3: An example of fibrocystic changes in a 35-year-old female.
The B-mode ultrasound image on the right indicates a hypoechoic
nodular lesion. On the color-coded elastography, the lesion appears
to be less strained than the surrounding tissues. The region of
interest (ROI A) is positioned in normal parenchyma, and the
second ROI B is positioned within the lesion. The strain index is
0.32; therefore, the lesion is most likely benign.
in adjacent structures, initial rise of the kinetic curve, and
washout. Further, every structural distortion was considered
suspicious.
6. Statistical Analysis
Lesions classified as BI-RADS 4 and 5 were considered
malignant and BI-RADS 3 lesions were assessed as benign
entity for sensitivity, specificity, and accuracy calculations.
To investigate the performance of real-time elastography
in comparison with an established testing method (con-
ventional ultrasound and mammography), the sensitivities
and specificities of both modalities for identifying malignant
lesions were determined. To compare the performance of
real-time elastography (RTE) with conventional ultrasound,
the sensitivity and specificity of bothmethodswere calculated
for malignant lesions using a two-dimensional contingency
table. These results were verified using positive and negative
likelihood ratio testing. The comparison between the size-
dependent sensitivity, specificity, and accuracy of the con-
ventional ultrasound combined with mammography against
real-time elastography was analyzed using the McNemar test
formatched, nominal data [11].Moreover, the differentmeans
of the different BI-RADS categories acquired by conventional
methods were compared against the measured strain indices
using one-way analysis of variance (ANOVA [12]). Given
normal distribution of the data, Wilcoxon rank-sum test [12]
was performed to compare the strain indices of themalignant
and benign lesions and to assess whether their population
mean ranks differ. A cutoff strain index for malignant lesions
with maximum sensitivity was determined using a receiver
operating characteristic (ROC) curve [12]. 𝑃 values less than
0.05 were considered statistically significant. Microsoft Excel
2003 (Microsoft, Redmond, USA) and MedCalc (v7 6.0.0
Ostend, Belgium) were used for statistical evaluations. For a
sample size of 31 cancers an increase in sensitivity for malig-
nancy from 90.3% (28 of 31 cancers) to 100% (31 of 31 cancers)
could be possible at a significance level of 5% (alpha-error)
with a power of 80% (beta-error). In other words, the sample
size is large enough to detect 3 additional cancers adding elas-
tography tomammography/sonographywith a power of 80%.
7. Results
A total of 110 lesionswere identified in 100 patients, consisting
of 31 malignant (𝑛 = 28.2%) and 79 benign lesions
(71.8%) (Table 2). Among the malignancies, there were 23
ductal carcinomas (74.2%), four lobular carcinomas (12.9%),
two mucinous carcinomas (6.5%), one papillary carcinoma
(3.2%), and one adenocarcinoma (3.2%). The average lesion
size was 14.7mm (range 4 to 110mm).
Forty-nine out of 110 lesions measured between 1 and
10mm (45%). Forty-three lesions measured 10mm to 20mm
(39%). Eighteen lesions had a diameter greater than 20mm
(16%).
7.1. Strain Indices in relation to BI-RADS Classification.
Table 3 lists the different BI-RADS scores and the distribu-
tion of the mean of the associated strain indices including
standard deviation. The mean strain index for BI-RADS 2
lesions was 1.71 ± 0.86 (±standard deviation). A slightly
higher scorewas observed for BI-RADS 3 lesions (2.21±1.96).
The strain index of theBI-RADS4 and 5 lesions demonstrated
significantly higher values (16.92 ± 20.89 and 19.54 ± 10.41,
resp.). Analysis of variance tested the SI (=strain index) for
the different BI-RADS levels together as significant (𝑃 value
< 0.0001).
7.2. Strain Indices and Histological Diagnosis. The 31 malig-
nant tumors featured a mean strain index of 16.13 ± 14.67,
whereas the benign tumors (𝑛 = 79, including BI-RADS
2, 3 and biopsy-proven benign lumps) only showed a mean
strain index of 5.29 ± 11.87 (𝑃 value ≤ 0.0001). The ductal
and lobular carcinomas exhibited the highest scores (17.43
and 45.13, resp.). Mastitis and scars both evinced low scores
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Table 2: Elasticity score for individual pathology and comparison
between malignant and benign disease.
Histology 𝑛= Mean SI1 SD2 Median SI
Ductal carcinoma 23 17.43 (±13.80) 9.40
Lobular carcinoma 4 45.13 (±33.06) 59.00
Mucinous carcinoma 2 7.00 (±4.24) 7.00
Adenocarcinoma 1 1.60 1.60
Papillary carcinoma 1 6.47 6.47
Malignant 31 18.69 (±17.56) 9.40
Fibrocystic mastopathy 7 15.27 (±18.56) 2.40
Adenosis 7 14.35 (±22.86) 6.10
Fibroadenoma 5 15.57 (±27.70) 4.57
Scar 2 1.85 (±0.92) 1.85
Fatty necrosis 1 10.80 10.80
Mastitis 1 2.00 2.00
Normal 56 2.82 (±5.25) 1.74
Benign 79 5.82 (±12.39) 2.20
1SI: strain index.
2SD: standard deviation.
Table 3: BIRADS scores and associated strain indices. Further, the
strain indices of malignant and benign lesions are displayed.
𝑛= Mean SI1 SD2
Histology
Malignancy 31 16.31 14.67
Benign lesions 79 5.29 11.87
Total 110
BI-RADS
2 35 1.71 0.86
3 30 2.21 1.96
4 33 16.92 20.89
5 12 19.54 10.41
Total 110
1SI: strain index.
2SD: standard deviation.
(2.00 and 1.85 ± 0.92). Examples of benign and malignant
disease scores are given in Figures 2 and 3. The ROC analysis
indicated a cutoff level for malignant disease at a strain
index of 3.8 (Figures 4 and 5). The accuracy of identifying
a malignant disease is highest with this criterion, with a
sensitivity of 93.5% (95%CI = 78.5%–99.0%) and a specificity
of 75.9% (95% CI = 65.0%–84.9%).
7.3. Accuracy of Real-Time Elastography and Mammogra-
phy in Combination with Ultrasound. Pooled sensitivity of
mammography and ultrasound for malignancy was 90.3%,
which was 3.2% higher than the sensitivity of elastosonog-
raphy alone (87.1%). The specificity of mammography and
conventional ultrasound (78.5%) was 1.4% lower than the
specificity of real-time elastography (79.7%). The overall
accuracy of mammography and ultrasound for malignancies
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Figure 4: Receiver operating characteristic (ROC): area under
the ROC curve = 0.861, standard error = 0.045, 95% Confidence
interval = 0.782 to 0.919, and disease prevalence = 28.2%. The ROC
analysis shows a cutoff level for malignant disease at an elastography
coefficient of >3.8. With this criterion accuracy for malignant
disease is highest with a sensitivity of 93.5 (95% C.I. = 78.5–99.0)
and specificity of 75.9 (95% C.I. = 65.0–84.9).
(81.8%) is the same as for elastosonography alone (Tables 4
and 5). All those findings did not prove to be statistically
significant.Therefore elastosonography alone is as accurate as
mammography and ultrasound together within our selected
study collective.
7.4. Size-Dependant Sensitivity and Specificity. Sensitivity
drops from 100% for lesions >2 cm to 77.8% for lesions <1 cm
for mammography in combination with the ultrasound (US).
Similar results arose for RTE alone, except lesions >2 cm
showed slightly lower sensitivity of 88.9% with RTE.
7.5. Performance of Elastosonography When Combined with
Ultrasound and Mammography. McNemar’s test did not
demonstrate a significant difference in sensitivity, specificity,
or accuracy for any size group between the combination of
mammography and ultrasound versus elastosonography. But
the analysis of variance (ANOVA) showed a highly significant
result for the association of BI-RADS categories and the
related strain indices (<0.0001). If a conventional method
and/or real-time elastography was positive for malignancy,
the combined classification counted as positive test result.
Using this approach, the detection rate for malignant lesions
increased from 28 to 30 (out of 31). In fact, sensitivity
advanced from 90.3% to 96.8%. Nevertheless the 𝑃 value
remained not significant (0.48). The 30 lesions classified as
BI-RADS 3 after mammography and US are displayed in a
separate Table (Table 6). RTE solely was able to reclassify the
6 ISRN Radiology
CA
70
60
50
40
30
20
10
0
01
>3.8
Sens.: 93.5
Spec.: 75.9
Strain index (SI)
Figure 5: Scatter plot for multivariate data providing the distribu-
tion of strain indices associatedwithmalignancy (1) andwith benign
lesions (0). The cutoff is set at 3.8 as calculated in the ROC analysis.
Table 4: Accuracy calculations for mammography and ultrasound
in combination.
TP1 FN2 TN3 FP4 Sens.5 Spec.6 Acc.7
>20mm 9 0 5 4 1.000 0.556 0.778
10–20mm 12 1 21 9 0.923 0.700 0.767
1–10mm 7 2 36 4 0.778 0.900 0.878
Total 28 3 62 17 0.903 0.785 0.818
1TP: true positive; 2FN: false negative; 3TN: true negative; 4FP: false positive;
5Sens.: sensitivity; 6Spec.: specificity; 7Acc.: accuracy.
Table 5: Accuracy calculations for real-time sonoelastography
scores.
TP1 FN2 TN3 FP4 Sens.5 Spec.6 Acc.7
>20mm 8 1 4 5 0.889 0.444 0.667
10–20mm 12 1 22 8 0.923 0.733 0.791
1–10mm 7 2 37 3 0.778 0.925 0.898
Total 27 4 63 16 0.871 0.797 0.818
1TP: true positive; 2FN: false negative; 3TN: true negative; 4FP: false positive;
5Sens.: sensitivity; 6Spec.: specificity; 7Acc.: accuracy.
two false negative BI-RADS 3 lesions asmalignant (sensitivity
100%). Altogether, the positive and negative likelihood ratios
for mammography and ultrasound combined, RTE alone,
and the combination of bothmethods are listed in Tables 4 to
7. A likelihood ratio >1 indicates a positive relation between
the test result and disease. A likelihood ration <1 is associated
with the absence of disease. Positive and negative likelihood
ratios for US, RTE, and the combined testing lie far from 1,
indicating practical significance as the posttest probability is
little different from the pretest probability.
8. Discussion
Ultrasound examinations are important clinical procedures
for determining the diagnosis of a breast lesion. This tech-
nique is especially important for patients with dense mam-
mary gland tissue (ACR values of 3 and 4) given that the
sensitivity of the mammography is low for these patients
[13]. Additionally, real-time elastography (RTE) can provide
real-time information on tissue composition during the same
session as the ultrasound. The strain index is an objec-
tive, measurable numerical value, and previous studies have
demonstrated a correlation between the BI-RADS categories
and strain indices [14]. A mean strain index of 1.71 and 2.21
was calculated for BI-RADS categories 2 and 3, respectively.
Those low strain indices for benign lumps correspond with
values reported in the literature [3, 15]. Highly suspicious
lesions (BI-RADS categories 4 and 5) exhibited strain indices
with average values of 16.9 and 19.5, respectively, indicat-
ing reduced elasticity. In BI-RADS 3 cases RTE was able
to identify all true positive, malignant lesions as good as
mammography and ultrasound combined (sensitivity 100%).
Given the nature of the BI-RADS-classification, sample size
of malignant lesions initially classified as BI-RADS 3 was low
(𝑛 = 2). But the fact that RTE could detect 2malignant lesions
classified as probably benign (BI-RADS 3) with conventional
sonography and mammography is promising and is worth
further investigation.
The ROC analysis we performed indicated that a strain
ratio of 3.8 is the cutoff level for malignant disease in the
present study. The mean cutoff value for malignancy that we
report is slightly lower than the one observed by Itoh et al.
(4.2±0.9) [7].The study conducted by Cho et al. [16] reported
a strain ratio of 3.9 as the cutoff formalignancy. Balleyguier et
al. also showed a cutoff point between 3 and 4 [17]. It is worth
mentioning that the SR is depending on the manufacturer of
the elastography unit [18].
Itoh et al. published a cutoff level for malignancy of 4.2
and used a handmade stabilizer to minimize rotation of the
probe on the skin surface maybe influencing the results.
Despite the fact that the sample size of Itoh et al. was similar
to our study population (111 patients versus 100 patients in
our group), Itoh et al. included 52 cases of breast cancer
versus 31 cases in our evaluation. Nevertheless, lesion size and
histological distribution were quite similar.
The comparison of elastography with conventional ultra-
sound and mammography, which was performed to deter-
mine whether any information was gained by performing
real-time elastography, was of particular interest. Conven-
tional ultrasound and mammography exhibited a sensitiv-
ity of 90.3% and a specificity of 78.5% for malignancy.
In contrast, real-time elastography alone demonstrated a
sensitivity of 87.1% and a specificity of 79.7%. The real-time
elastography results for mammary lesions as compared with
conventional ultrasound findings were similar to previously
reported findings. According to Thomas et al., [15] B-mode
ultrasound achieved a sensitivity of 91.8% and a specificity of
78%. By combining ultrasound with real-time elastography,
a specificity of 91.5% may be achieved. The study by Itoh et
al. indicated a sensitivity of 86.5% and a specificity of 89.8%
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Table 6: Accuracy calculations for BI-RADS 3 lesions.
TP1 FN2 TN3 FP4 Sens.5 Spec.6 Acc.7
𝑛 = 30 2 0 26 2 1 0.929 0.933
PPV8 50.00% CI 95% 8.30–91.70% PLR10 14 CI 95%12 3.68–53.23
NPV9 100.00% CI 95% 86.65–100.00% NLR11 0
1TP: true positive; 2FN: false negative; 3TN: true negative; 4FP: false positive; 5Sens.: sensitivity; 6Spec.: specificity; 7Acc.: accuracy; 8PPV: positive predictive
value; 9NPV: negative predictive value; 10PLR: positive likelihood ratio; 11NLR: negative likelihood ratio; 12CI: confidence interval.
Table 7: Accuracy calculations for the combination of mammography, sonography and RTE.
TP FN TN FP Sens. Spec. Acc.
𝑛= 30 1 60 19 0.968 0.759 0.818
PPV 61.22% CI 95% 46.24–74.80% PLR 4.02 CI: 2.71–5.99
NPV 98.36% CI 95% 91.17–99.73% NLR 0.04 CI: 0.01–0.27
for elastography compared with a lower sensitivity (71.2%)
and a higher specificity (96.6%) for ultrasound. As suggested
by Itoh et al., we created ten-millimeter categories of lesion
size to investigate the connection between lesion size and
the accuracy of real-time elastography versus conventional
ultrasound. The results are displayed in Tables 4 and 5. For
larger masses (≥20mm), the specificity, and therefore the
accuracy, was higher for conventional ultrasound analysis.
This result is likely due to the fact that larger lesions have
a certain degree of stiffness. By placing the ROI within the
periphery of a lesion, away from the probe, the mass in the
ROI is less compressible. The mass between the ROI and
the probe may neutralize the applied pressure. Therefore,
we suggest that the ROI for larger tumors should be placed
as close to the probe as possible; however, further studies
should be performed to verify this hypothesis. The present
test results indicate that higher accuracy for malignancy may
be achieved by combining conventional methods with real-
time elastography, but a larger study population is needed to
get statistically significant results.
Furthermore, an elevated strain index may point towards
a special malignant entity. The average strain indices mea-
sured for ductal carcinomas were 17.43 ± 13.80 and an
average score of 45.13 ± 33.06 was measured for lobular
carcinomas. The histopathologic correlation is limited by
the prominent variation from the average SI represented by
a broad deviation of values. According to Zhi et al., [19]
mucinous carcinomas can exhibit benign-appearing strain
indices in early elastography examinations.This finding could
not be confirmed by our test results or by other evaluations
[18]. We found a mean strain index of 7 ± 4.24 in two cases of
mucinous carcinomas.
9. Limitations
Despite the promising results presented here with respect
to the diagnostic power of real-time elastography, some
limitations of our study should be considered. The number
of histological malignant tumors among the patient sample
was relatively small (31 cases, 28.18%), but the prospective
evaluation of more patients is ongoing. One limitation in the
study is the high number of nonpathologically proved pre-
sumed benign lesions (BI-RADS 2 and 3); they compromise
71% from the study cases. Due to this small number of cases in
our cohort, it is not possible to provide representative infor-
mation for all carcinoma entities. Furthermore, it is known
that the acquisition and the interpretation of elastography
images by radiologists are clearly subjective [20, 21]. Also the
measured strain indices showed a broad variation. A recent
study demonstrated that breast thickness is also a limiting
factor in diagnostic specificity [22].
10. Conclusion
Despite the limitations mentioned above, our study demon-
strated that real-time elastography is a promising method
for increasing the accuracy of conventional sonography in
a clinical setting. We were able to show that especially
in BI-RADS 3 lesions the use of RTE could increase the
sensitivity for malignancy in this category. In a clinical
routine setting, we were able to elevate the detection rate of
malignant lesions from 28 to 30 (𝑛 total = 31) suggesting
the beneficial implementation of real-time elastography in
clinical examinations. In fact, three BI-RADS 3 lesions could
be reclassified with RTE and were proven to be malignant.
This suggests that the use of RTE is especially valuable for the
characterisation of BI-RADS 3 rated lesions.
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